Hepatocellular Toxicity Associated with Tyrosine Kinase Inhibitors: Mitochondrial Damage and Inhibition of Glycolysis
出版年份 2017 全文链接
标题
Hepatocellular Toxicity Associated with Tyrosine Kinase Inhibitors: Mitochondrial Damage and Inhibition of Glycolysis
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2017-06-14
DOI
10.3389/fphar.2017.00367
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Development and Validation of a Simultaneous Quantification Method of 14 Tyrosine Kinase Inhibitors in Human Plasma Using LC-MS/MS
- (2017) Huu H. Huynh et al. THERAPEUTIC DRUG MONITORING
- P450 3A-Catalyzed O-Dealkylation of Lapatinib Induces Mitochondrial Stress and Activates Nrf2
- (2016) Marsha Rebecca Eno et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Long-Term Side Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
- (2016) Lauren Caldemeyer et al. Current Hematologic Malignancy Reports
- Comparison of Liver Cell Models Using the Basel Phenotyping Cocktail
- (2016) Benjamin Berger et al. Frontiers in Pharmacology
- Hepatotoxicity with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A meta-analysis of randomized clinical trials
- (2015) Pooja Ghatalia et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Sunitinib-ibuprofen drug interaction affects the pharmacokinetics and tissue distribution of sunitinib to brain, liver, and kidney in male and female mice differently
- (2015) Christine Li Ling Lau et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Regorafenib impairs mitochondrial functions, activates AMP-activated protein kinase, induces autophagy, and causes rat hepatocyte necrosis
- (2015) Zuquan Weng et al. TOXICOLOGY
- Lapatinib Plasma and Tumor Concentrations and Effects on HER Receptor Phosphorylation in Tumor
- (2015) Neil L. Spector et al. PLoS One
- Dual response of the KATP channels to staurosporine: A novel role of SUR2B, SUR1 and Kir6.2 subunits in the regulation of the atrophy in different skeletal muscle phenotypes
- (2014) Antonietta Mele et al. BIOCHEMICAL PHARMACOLOGY
- Toxicity of targeted therapy: Implications for response and impact of genetic polymorphisms
- (2014) Sariah Liu et al. CANCER TREATMENT REVIEWS
- Formation of reactive metabolites and management of tyrosine kinase inhibitor-induced hepatotoxicity: a literature review
- (2014) Yi Ling Teo et al. Expert Opinion on Drug Metabolism & Toxicology
- Fulminant Hepatitis Following Crizotinib Administration for ALK-positive Non-small-cell Lung Carcinoma
- (2014) Y. Sato et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Hepatic toxicity of dronedarone in mice: Role of mitochondrial β-oxidation
- (2014) Andrea Felser et al. TOXICOLOGY
- Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy
- (2013) Roberto Iacovelli et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Hepatotoxicity of Tyrosine Kinase Inhibitors: Clinical and Regulatory Perspectives
- (2013) Rashmi R. Shah et al. DRUG SAFETY
- Occurrence and current management of side effects in chronic myeloid leukemia patients treated frontline with tyrosine kinase inhibitors
- (2013) Massimo Breccia et al. LEUKEMIA RESEARCH
- Genetic characterization to improve interpretation and clinical management of hepatotoxicity caused by tyrosine kinase inhibitors
- (2013) Colin F Spraggs et al. PHARMACOGENOMICS
- Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors
- (2013) Debra H. Josephs et al. THERAPEUTIC DRUG MONITORING
- Potential of ponatinib to treat chronic myeloid leukemia and acute lymphoblastic leukemia
- (2013) Michael Steinberg et al. OncoTargets and Therapy
- Lapatinib-Induced Liver Injury Characterized by Class II HLA and Gilbert's Syndrome Genotypes
- (2012) C F Spraggs et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Severe Pazopanib-Induced Hepatotoxicity: Clinical and Histologic Course in Two Patients
- (2012) Samuel J. Klempner et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanisms of Hepatocellular Toxicity Associated with Dronedarone—A Comparison to Amiodarone
- (2012) Andrea Felser et al. TOXICOLOGICAL SCIENCES
- Oxidative stress is involved in Dasatinib-induced apoptosis in rat primary hepatocytes
- (2012) Tao Xue et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Mitochondrial Regulation of Cell Cycle and Proliferation
- (2011) Valeria Gabriela Antico Arciuch et al. ANTIOXIDANTS & REDOX SIGNALING
- HLA-DQA1*02:01 Is a Major Risk Factor for Lapatinib-Induced Hepatotoxicity in Women With Advanced Breast Cancer
- (2011) Colin F. Spraggs et al. JOURNAL OF CLINICAL ONCOLOGY
- Metronidazole leads to enhanced uptake of imatinib in brain, liver and kidney without affecting its plasma pharmacokinetics in mice
- (2011) Shin Yee Tan et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Mechanisms of drug-induced liver injury: from bedside to bench
- (2011) Shannan Tujios et al. Nature Reviews Gastroenterology & Hepatology
- The role of CYP3A4 in amiodarone-associated toxicity on HepG2 cells
- (2010) Anja Zahno et al. BIOCHEMICAL PHARMACOLOGY
- Polymerase γ Gene POLG determines the risk of sodium valproate-induced liver toxicity
- (2010) Joanna D. Stewart et al. HEPATOLOGY
- Mechanism-Based Inactivation of Cytochrome P450 3A4 by Lapatinib
- (2010) W. C. Teng et al. MOLECULAR PHARMACOLOGY
- Three cases of severe hepatic impairment caused by erlotinib
- (2009) Yi-Sheng Huang et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial
- (2009) Martin E Gore et al. LANCET ONCOLOGY
- Role of Hepatic Transporters in the Disposition and Hepatotoxicity of a HER2 Tyrosine Kinase Inhibitor CP-724,714
- (2009) Bo Feng et al. TOXICOLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search